Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aditxt Inc
(NQ:
ADTX
)
2.390
-0.140 (-5.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Aditxt Inc
< Previous
1
2
3
4
5
6
Next >
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
April 02, 2024
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Acquisition Target Reports Increased Product Sales, Ongoing Revenue Growth
March 27, 2024
Via
Investor Brand Network
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Potential Acquisition Releases FY 2023 Preliminary Financial Report
February 01, 2024
Via
Investor Brand Network
Aditxt Inc. (NASDAQ: ADTX) Leading the Way in Wednesday Trading Based on Percentage Gain
August 23, 2023
Via
Investor Brand Network
Aditxt Inc. (NASDAQ: ADTX) Leading the Way in Friday Trading Based on Percentage Gain
August 18, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Acquires Proprietary EEG Portfolio
January 30, 2024
Via
Investor Brand Network
Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications
January 30, 2024
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX), Subsidiary Pearsanta Announce Acquisition of MDNA Life Sciences Inc.’s Mitomic(TM) Testing Platform
January 08, 2024
Via
Investor Brand Network
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
January 08, 2024
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Secures $6M in Private Placement
January 05, 2024
Via
Investor Brand Network
Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
January 05, 2024
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Regains NASDAQ Compliance, Announces $6M Private Placement
January 02, 2024
Via
Investor Brand Network
Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
January 02, 2024
From
Aditxt, Inc.
Via
Business Wire
Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules
December 29, 2023
From
Aditxt, Inc.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk Shipping Inc. (NYSE - EGLE), Icosavax, Inc. (Nasdaq - ICVX), Evofem Biosciences, Inc. (OTC - EVFM), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
December 18, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Definitive Agreement to Acquire Evofem Biosciences Inc.
December 12, 2023
Via
Investor Brand Network
ADTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aditxt, Inc. Is Fair to Shareholders
December 12, 2023
From
Halper Sadeh LLC
Via
Business Wire
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
December 12, 2023
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Participation at 8th Annual Dawson James Conference
October 06, 2023
Via
Investor Brand Network
Aditxt, Inc. to Present at 8th Annual Dawson James Conference
October 06, 2023
Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12, 2023
From
Aditxt, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Pearsanta Appoints Ernie Lee as CEO to Drive Launch of Test2Treat.me Platform
October 05, 2023
Via
Investor Brand Network
Aditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me Platform
October 05, 2023
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Exec to Present at Upcoming H.C. Wainwright Global Investment Conference
September 08, 2023
Via
Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference September 11th-13th, 2023
September 08, 2023
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on $10M Private Placement
September 07, 2023
Via
Investor Brand Network
Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
September 06, 2023
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) to Enter $10M Private Placement Agreements
September 01, 2023
Via
Investor Brand Network
Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
August 31, 2023
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Issues Planned Strategy for Achieving Commercial Scale, Updated Release on 1-for-40 Reverse Split
August 18, 2023
Via
Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale
August 18, 2023
From
Aditxt, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.